Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to developing innovative therapies for genetically defined diseases with significant unmet medical needs. The company focuses on conditions such as Duchenne Muscular Dystrophy and employs a proprietary drug discovery platform to support a robust pipeline of therapeutic candidates. With a strong commitment to precision medicine, Fulcrum Therapeutics aims to deliver targeted treatments that can enhance patient care and significantly improve the quality of life for individuals suffering from these challenging disorders. Show more

Location: 26 LANDSDOWNE STREET, CAMBRIDGE, MA, UNITED STATES, 02139, Cambridge, MA, 02139, USA | Website: https://www.fulcrumtx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

630M

52 Wk Range

$2.31 - $15.74

Previous Close

$9.55

Open

$9.71

Volume

489,219

Day Range

$9.62 - $10.00

Enterprise Value

458.8M

Cash

47.08M

Avg Qtr Burn

-14.19M

Insider Ownership

1.23%

Institutional Own.

77.79%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Pociredir (FTX-6058) Details Sickle cell disease	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Losmapimod Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Losmapimod Details Muscle degeneration, Muscle weakness, Facioscapulohumeral muscular dystrophy	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.